search
Back to results

Vitamin D in School Children (DVinCHI)

Primary Purpose

Vitamin D Deficiency, Musculoskeletal Diseases, Cognitive Delay, Mild

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Oral vitamin D spray
Placebo
Sponsored by
University of Ulster
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Vitamin D Deficiency focused on measuring Vitamin D, Deficiency, vitamin D3, supplementation, Cholecalciferol, school children, paediatric, 25(OH)D, hypovitaminosis D, postural balance, cognitive function

Eligibility Criteria

4 Years - 11 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy children aged 4-11 years attending school in Northern Ireland.

Exclusion Criteria:

  • Any children on long-term prescription medication; and/or diagnosed with a long-term or exacerbated health condition or disease (does not exclude children with minor or mild health conditions).
  • Those previously taking a vitamin D supplement and those not willing to abstain from starting vitamin D supplements.
  • Those using home sun beds.
  • Those who are planning a family holiday to a sunny country (latitudes below 37°N) during the duration of the intervention.

Sites / Locations

  • Human Intervention Studies Unit, Ulster UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Oral vitamin D3 spray

Placebo Comparator

Arm Description

10µg/day for 12 weeks (BetterYou ltd.)

Xylitol (BetterYou ltd.)

Outcomes

Primary Outcome Measures

Plasma 25-hydroxy vitamin D concentration
Measured by LC/MS

Secondary Outcome Measures

Muscle strength
Hand grip strength by a dynamometer
Postural balance
Assessed using single leg stance (SLS)
Postural balance
Assessed using tandem stance (TS)
Cognitive function
Assessed using three CANTAB batteries

Full Information

First Posted
August 17, 2021
Last Updated
August 23, 2021
Sponsor
University of Ulster
Collaborators
Queen Margaret University, Nutrition and Biological Sciences, Musselburgh, Scotland, UK, Better You ltd., Unit 24 Shortwood Court, Shortwood Business Park, Dearne Valley Parkway, Barnsley, S74 9LH, Registered Company No: 05541287
search

1. Study Identification

Unique Protocol Identification Number
NCT05018988
Brief Title
Vitamin D in School Children
Acronym
DVinCHI
Official Title
The D-VinCHI Study: 25-hydroxyvitamin D Concentration in School Children: Effects of Vitamin D3 Supplementation on 25-OH-D Concentration and Muscle Health Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
October 30, 2025 (Anticipated)
Study Completion Date
October 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Ulster
Collaborators
Queen Margaret University, Nutrition and Biological Sciences, Musselburgh, Scotland, UK, Better You ltd., Unit 24 Shortwood Court, Shortwood Business Park, Dearne Valley Parkway, Barnsley, S74 9LH, Registered Company No: 05541287

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary purpose of this study it to investigate total circulating 25-hydroxyvitamin D (25(OH)D) in school children (aged 4-11years) in Northern Ireland; thereby establishing the prevalence of vitamin D status (deficiency, insufficiency, and sufficiency (SACN 2016)) in this cohort. Additionally, the study aims to determine if 10µg/day vitamin D3 supplementation over 12 weeks maintains vitamin D status. This area of research is lacking in the quality of prospective studies. While previous literature has focused on the prevalence of vitamin D status in adults, there is a paucity of data available for children. This study will add to the existing knowledge and provide more specific analysis for children. Hypothesis 1: Increase in vitamin D concentrations will be associated with an improvement in health outcomes including anthropometric measurements, musculoskeletal outcomes, markers of inflammation, nutritional status and bone turnover, lipid profiles, cognitive function, and handgrip strength.
Detailed Description
The main objectives of this study are to determine prevalence of vitamin D status in 4-11-year-old children and to investigate if 10µg/day maintains vitamin D status in this population. This study will focus on children aged 4-11 years old residing in Northern Ireland. This 2-phase study will incorporate an observational phase and intervention phase to determine prevalence and status, respectively. The expected time under study will be 12 weeks and the number of visits will be limited to two per participant. Where participants are from the same home, randomisation to the same treatment group will occur. Results will be controlled for season. Vitamin D deficiency is prevalent across the global population including those who reside above 37° North. In addition to a lack of rich dietary sources of vitamin D, residing at this latitude restricts exposure to sunlight due to the zenith angle of the sun. Although vitamin D deficiency is rife in the general population there are certain categories who are at additional risk of vitamin D deficiency including pregnant women, elderly, and institutionalized populations. One population group where there is still a paucity of studies, and a lack of clear guidelines are children. Recent evidence suggests that vitamin D has potential to provide extra skeletal health benefits. Assessments to be undertaken in this study include anthropometric, handgrip, balance, cognitive function. These assessments will be followed by a 20ml blood draw completed by a trained researcher who is trained in phlebotomy. Additionally, parents will be asked to complete a validated vitamin D food frequency questionnaire and four-day weighed diet diary for their offspring. This study will determine if the recommended supplementation regimen results in the intervention population reporting a sufficient vitamin D status. Blood samples will be analysed for 25(OH)D, serum parathyroid hormone (PTH), serum C-reactive protein (CRP), serum HbA1c (glycated haemoglobin), markers of bone turnover, markers of inflammation, full blood count, lipid profile, and markers of nutritional status. Circulating 25(OH)D will be assessed via liquid chromatography- mass spectrometry (HPLC & MS). Sample size was calculated using G*Power software available at QMU (G*Power) by entering the planned statistical analysis method (i.e. t-test or ANOVA), desired effect size (0.5), and experimental design (i.e. two groups with two outcomes). Phase one (observational study) with an effect size of 0.15 requires a total population of 200. Phase two (intervention study) with an effect size of 0.15 requires a total population of 118 (59 in each arm) including a dropout rate of 20%. A total population of 55 is required for Food frequency validation including a 10% dropout rate and for the vitamin D knowledge questionnaire with an effect size of 0.8 a total population of 70 is required. The planned statistical analysis will be conducted in IBM SPSS and with intention to treat. Results from phase one will be analysed using descriptive statistics. A regression model will be used to determine prediction models for circulating 25(OH)D and the reported secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin D Deficiency, Musculoskeletal Diseases, Cognitive Delay, Mild
Keywords
Vitamin D, Deficiency, vitamin D3, supplementation, Cholecalciferol, school children, paediatric, 25(OH)D, hypovitaminosis D, postural balance, cognitive function

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Observational study followed double blinded randomised control trial
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Double blinded to participant and researcher
Allocation
Randomized
Enrollment
118 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Oral vitamin D3 spray
Arm Type
Experimental
Arm Description
10µg/day for 12 weeks (BetterYou ltd.)
Arm Title
Placebo Comparator
Arm Type
Placebo Comparator
Arm Description
Xylitol (BetterYou ltd.)
Intervention Type
Dietary Supplement
Intervention Name(s)
Oral vitamin D spray
Other Intervention Name(s)
vitamin D3
Intervention Description
1 spray (10µg) /day for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Other Intervention Name(s)
Xylitol
Intervention Description
1 spray / day for 12 weeks
Primary Outcome Measure Information:
Title
Plasma 25-hydroxy vitamin D concentration
Description
Measured by LC/MS
Time Frame
Change over 12 weeks
Secondary Outcome Measure Information:
Title
Muscle strength
Description
Hand grip strength by a dynamometer
Time Frame
Change over 12 weeks
Title
Postural balance
Description
Assessed using single leg stance (SLS)
Time Frame
Change over 12 weeks
Title
Postural balance
Description
Assessed using tandem stance (TS)
Time Frame
Change over 12 weeks
Title
Cognitive function
Description
Assessed using three CANTAB batteries
Time Frame
Change over 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy children aged 4-11 years attending school in Northern Ireland. Exclusion Criteria: Any children on long-term prescription medication; and/or diagnosed with a long-term or exacerbated health condition or disease (does not exclude children with minor or mild health conditions). Those previously taking a vitamin D supplement and those not willing to abstain from starting vitamin D supplements. Those using home sun beds. Those who are planning a family holiday to a sunny country (latitudes below 37°N) during the duration of the intervention.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pamela J Magee
Phone
+44 28 7012 4360
Email
pj.magee@ulster.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Emeir McSorley
Phone
+4402870123543
Email
em.mcsorley@ulster.ac.uk
Facility Information:
Facility Name
Human Intervention Studies Unit, Ulster University
City
Coleraine
State/Province
Londonderry
ZIP/Postal Code
BT52 1SA
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ruth Price
Phone
+442870123878
Email
rk.price@ulster.ac.uk
First Name & Middle Initial & Last Name & Degree
Julie Sittlington
Phone
+442870124101
Email
jj.sittlington@ulster.ac.uk

12. IPD Sharing Statement

Learn more about this trial

Vitamin D in School Children

We'll reach out to this number within 24 hrs